This bill amends Minnesota Statutes 2024, section 256B.0625, subdivision 13f, to prohibit the use of prior authorization and step therapy for drugs approved by the United States Food and Drug Administration for the treatment of opioid use disorder under medical assistance. The new legal language specifies that, notwithstanding any existing laws, these requirements shall not be applied to this class of drugs, ensuring that individuals seeking treatment for opioid use disorder can access necessary medications without additional barriers.

Additionally, the bill makes several deletions and modifications to existing provisions regarding prior authorization for various drugs. Notably, it removes the requirement for prior authorization for liquid methadone and clarifies the conditions under which prior authorization may be required for other medications. The changes aim to streamline access to essential medications while maintaining oversight for drugs that may require prior authorization under different circumstances.

Statutes affected:
Introduction: 256B.0625